Cargando…

Neurocognitive Function in HIV Infected Patients on Antiretroviral Therapy

OBJECTIVE: To describe factors associated with neurocognitive (NC) function in HIV-positive patients on stable combination antiretroviral therapy. DESIGN: We undertook a cross-sectional analysis assessing NC data obtained at baseline in patients entering the Protease-Inhibitor-Monotherapy-Versus-Ong...

Descripción completa

Detalles Bibliográficos
Autores principales:	Winston, Alan, Arenas-Pinto, Alejandro, Stöhr, Wolfgang, Fisher, Martin, Orkin, Chloe M., Aderogba, Kazeem, De Burgh-Thomas, Andrew, O'Farrell, Nigel, Lacey, Charles JN., Leen, Clifford, Dunn, David, Paton, Nicholas I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3639991/ https://www.ncbi.nlm.nih.gov/pubmed/23646111 http://dx.doi.org/10.1371/journal.pone.0061949

Ejemplares similares

Neurocognitive Function in HIV-Infected Patients: Comparison of Two Methods to Define Impairment
por: Arenas-Pinto, Alejandro, et al.
Publicado: (2014)

Protease inhibitor monotherapy for long-term management of HIV infection: a randomised, controlled, open-label, non-inferiority trial
por: Paton, Nicholas I, et al.
Publicado: (2015)

Next generation sequencing of HIV-1 protease in the PIVOT trial of protease inhibitor monotherapy
por: Dunn, David T., et al.
Publicado: (2018)

Virological outcomes of boosted protease inhibitor-based first-line ART in subjects harbouring thymidine analogue-associated mutations as the sole form of transmitted drug resistance
por: Geretti, Anna Maria, et al.
Publicado: (2019)

Cost-effectiveness analysis of protease inhibitor monotherapy vs. ongoing triple-therapy in the long-term management of HIV patients
por: Oddershede, Lars, et al.
Publicado: (2014)

Impact on life expectancy of HIV-1 positive individuals of CD4(+) cell count and viral load response to antiretroviral therapy
por: May, Margaret T., et al.
Publicado: (2014)

Emergent Resistance to Dolutegravir Among INSTI-Naïve Patients on First-line or Second-line Antiretroviral Therapy: A Review of Published Cases
por: Cevik, Muge, et al.
Publicado: (2020)

The ‘Antiretrovirals, Sexual Transmission Risk and Attitudes’ (ASTRA) Study. Design, Methods and Participant Characteristics
por: Speakman, Andrew, et al.
Publicado: (2013)

Teaching wilderness first aid in a remote First Nations community: the story of the Sachigo Lake Wilderness Emergency Response Education Initiative
por: Born, Karen, et al.
Publicado: (2012)

Neurocognitive Impairment in Patients Treated with Protease Inhibitor Monotherapy or Triple Drug Antiretroviral Therapy
por: Pérez-Valero, Ignacio, et al.
Publicado: (2013)

Antiretroviral therapy improves neurocognitive impairment in people living with HIV? A meta-analysis
por: Gao, Chang, et al.
Publicado: (2020)

Aging, neurocognitive impairment and adherence to antiretroviral therapy in human immunodeficiency virus-infected individuals
por: Pinheiro, Cezar Arthur Tavares, et al.
Publicado: (2016)

Neurocognitive performance and quality of life of older adults with HIV on antiretroviral treatment in Northern Thailand
por: Aurpibul, Linda, et al.
Publicado: (2022)

Factors Associated With Nonadherence to Antiretroviral Therapy Among Young People Living With Perinatally Acquired HIV in England
por: Judd, Ali, et al.
Publicado: (2020)

Five Myths about the HIV Epidemic in Asia
por: Godwin, Peter, et al.
Publicado: (2006)

HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors
por: Heaton, Robert K., et al.
Publicado: (2010)

Enteric Fever
por: O'Farrell, T.
Publicado: (1872)

Absence of neurocognitive disadvantage associated with paediatric HIV subtype A infection in children on antiretroviral therapy
por: Bangirana, Paul, et al.
Publicado: (2017)

Prevalence and Correlates of Neurocognitive Disorders among HIV Patients on Antiretroviral Therapy at a Kenyan Hospital
por: Mugendi, A. G., et al.
Publicado: (2019)

Screening for HIV-Associated Neurocognitive Impairment: Relevance of Psychological Factors and Era of Commencement of Antiretroviral Therapy
por: Herrmann, Susan, et al.
Publicado: (2019)

Enteric Fever
por: O'Farrell, Thomas
Publicado: (1874)

Indian Fevers
por: O'Farrell, Thomas
Publicado: (1874)

Evolution in Lateral Flow–Based Immunoassay Systems
por: O’Farrell, Brendan
Publicado: (2008)

Where There Is No Paramedic: The Sachigo Lake Wilderness Emergency Response Education Initiative
por: Orkin, Aaron, et al.
Publicado: (2012)

Exploring HIV-Associated Neurocognitive Impairment in the Era of Effective Antiretroviral Therapy: A Primary Healthcare Perspective
por: Munsami, Adele, et al.
Publicado: (2022)

Quiescence: early evolutionary origins and universality do not imply uniformity
por: O'Farrell, Patrick H.
Publicado: (2011)

Introduction to Maple programming
por: O'Farrell, Anthony G
Publicado: (2005)

Laboratory adverse events and discontinuation of therapy according to CD4(+) cell count at the start of antiretroviral therapy
por: Jose, Sophie, et al.
Publicado: (2014)

Antiretroviral treatment initiation does not differentially alter neurocognitive functioning over time in youth with behaviorally acquired HIV
por: Nichols, Sharon L., et al.
Publicado: (2015)

The Presence of Human Immunodeficiency Virus-Associated Neurocognitive Disorders Is Associated With a Lower Adherence to Combined Antiretroviral Treatment
por: Kamal, Susan, et al.
Publicado: (2017)

Psycho-behavioral factors associated with neurocognitive performance among people living with HIV on antiretroviral therapy in Accra, Ghana
por: Asiedu, Nana, et al.
Publicado: (2020)

Prevalence of Neurocognitive Impairment and Associated Factors Among People Living with HIV on Highly Active Antiretroviral Treatment, Ethiopia
por: Wubetu, Abate Dargie, et al.
Publicado: (2021)

Phototest for neurocognitive screening in multiple sclerosis
por: Pinto, Joana, et al.
Publicado: (2016)

Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study
por: May, Margaret, et al.
Publicado: (2011)

Multitype violence exposures and adolescent antiretroviral nonadherence in South Africa
por: Cluver, Lucie, et al.
Publicado: (2018)

HPV vaccination in HIV infection
por: Lacey, Charles JN.
Publicado: (2019)

Unresolved issues in the management of human papillomavirus-associated mucosal high-grade pre-cancers
por: Lacey, Charles JN.
Publicado: (2023)

Significant Effects of Antiretroviral Therapy on Global Gene Expression in Brain Tissues of Patients with HIV-1-Associated Neurocognitive Disorders
por: Borjabad, Alejandra, et al.
Publicado: (2011)

Three-decade neurological and neurocognitive follow-up of HIV-1-infected patients on best-available antiretroviral therapy in Finland
por: Heikinheimo, T, et al.
Publicado: (2015)

Aberrant Autophagy in Macrophages and Astrocytes after HIV Nef or Antiretroviral Treatment: Contribution to the Pathogenesis of HIV-associated Neurocognitive Disorders
por: Cheney, Laura, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_mnddin1f0v1ll3a0cf2jodmls6